Related references
Note: Only part of the references are listed.A novel 2-pyrone derivative, BHP, impedes oncogenic KRAS-driven malignant progression in breast cancer
Rae-Kwon Kim et al.
CANCER LETTERS (2013)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment-Poor Prognosis or New Therapeutic Opportunity
Lisa A. Ridnour et al.
CLINICAL CANCER RESEARCH (2013)
hCAF1/CNOT7 regulates interferon signalling by targeting STAT1
Clement Chapat et al.
EMBO JOURNAL (2013)
NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression
Hirokazu Okayama et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The metastasis-promoting roles of tumor-associated immune cells
Heath A. Smith et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response
Anika Nagelkerke et al.
BREAST CANCER RESEARCH (2013)
S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
Christopher H. Switzer et al.
MOLECULAR CANCER RESEARCH (2012)
Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation
Lisa A. Ridnour et al.
PLOS ONE (2012)
miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes
Zhong Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
Christopher H. Switzer et al.
BREAST CANCER RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The Two Faces of Interferon-γ in Cancer
M. Raza Zaidi et al.
CLINICAL CANCER RESEARCH (2011)
Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment
Marco Tafani et al.
CANCER SCIENCE (2010)
Nitric Oxide and Pancreatic Cancer Pathogenesis, Prevention, and Treatment
Liwei Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients
Sharon A. Glynn et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Induction of autophagic cell death by a novel molecule is increased by hypoxia
Marco Tafani et al.
AUTOPHAGY (2008)
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis
Elizabeth A. Grimm et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells
Nikolai N. Khodarev et al.
CANCER RESEARCH (2007)
Tumor iNOS predicts poor survival for stage III melanoma patients
Suhendan Ekmekcioglu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS
S Loibl et al.
PATHOLOGY RESEARCH AND PRACTICE (2006)
Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells
GC Chan et al.
JOURNAL OF IMMUNOLOGY (2005)
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo
WK Alderton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Share Paper
